{ "docId": "019de077-4c75-7299-85f2-8570aa012761", "docSlug": "bc27eff688e591dce79cc29b4a79cc4b", "documentTitle": "Starboard Value | Activist Presentation Deck | 74 slides", "authorId": "starboard-value", "authorName": "Starboard Value", "documentKindSlug": "activist-deck", "documentKindLabel": "Activist deck", "sourceTypeSlug": "activist_investor", "sourceTypeLabel": "Activist investor", "presentationDate": "2024-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 15, "pageCount": 74, "prevPage": 14, "nextPage": 16, "slideType": "ceo_quote", "function": "expose_contradiction", "density": "dense", "nDataPoints": 1, "notes": "The slide uses a quote to highlight a specific management commitment, likely to be contrasted with later performance.", "elementsJson": null, "metadataConfidence": 1, "imagePath": null, "slideHref": "/slides/019de077-4c75-7299-85f2-8570aa012761/15", "deckHref": "/decks/019de077-4c75-7299-85f2-8570aa012761", "deckJsonHref": "/decks/019de077-4c75-7299-85f2-8570aa012761.json", "deckAnchorHref": "/decks/019de077-4c75-7299-85f2-8570aa012761#slide-15", "components": [ { "bbox": { "h": 0.05, "w": 0.94, "x": 0.03, "y": 0.895 }, "kind": "callout", "text": "Pfizer management committed to “constant flow” of innovation – as highlighted by 15 potential blockbusters.", "attrs": null, "subkind": "primary", "toolName": null, "toolSlug": null, "confidence": null, "componentId": "5be6569c-607a-4f82-b870-e9576aac5a6a", "frameworkName": null, "frameworkSlug": null }, { "bbox": { "h": 0.15, "w": 0.08, "x": 0.07, "y": 0.215 }, "kind": "image", "text": "Keyur Parekh", "attrs": null, "subkind": "headshot", "toolName": null, "toolSlug": null, "confidence": null, "componentId": "0c50c905-16d7-4731-99d3-e3a1e3dfdde7", "frameworkName": null, "frameworkSlug": null }, { "bbox": { "h": 0.18, "w": 0.1, "x": 0.86, "y": 0.505 }, "kind": "image", "text": "Albert Bourla", "attrs": null, "subkind": "headshot", "toolName": null, "toolSlug": null, "confidence": null, "componentId": "a3b08696-04d7-474e-81aa-2169ac8feaa6", "frameworkName": null, "frameworkSlug": null }, { "bbox": { "h": 0.04, "w": 0.94, "x": 0.03, "y": 0.15 }, "kind": "paragraph", "text": "Excerpt From 2019 Goldman Sachs Conference (January 3, 2019)", "attrs": null, "subkind": "paragraph", "toolName": null, "toolSlug": null, "confidence": null, "componentId": "d94a2ef5-566d-4091-9452-4049bae67c2b", "frameworkName": null, "frameworkSlug": null }, { "bbox": { "h": 0.1, "w": 0.815, "x": 0.155, "y": 0.215 }, "kind": "quote", "text": "But as you think about what markers you want to set for the company in the near term, so maybe in 12 months' time, kind of on a 3-year view or a 5-year view, how do you deem success over the short term?:", "attrs": null, "subkind": "pull-quote", "toolName": null, "toolSlug": null, "confidence": null, "componentId": "3e2710f5-eb9c-468b-95cb-77e9a39254d8", "frameworkName": null, "frameworkSlug": null }, { "bbox": { "h": 0.25, "w": 0.775, "x": 0.035, "y": 0.405 }, "kind": "quote", "text": "I think -- well, it's inevitable that for every CEO, the success is measured through -- with total shareholder return... So a way to measure it, for us, it is we have put out there a list of 15 potential blockbusters that could come by the year -- in 5 years, so it is by 2022 when we put it out in '18. And I think my focus would be to make sure that we deliver more than our fair risk adjustment of this number, and that will be success.", "attrs": null, "subkind": "pull-quote", "toolName": null, "toolSlug": null, "confidence": null, "componentId": "3ebc207e-e313-4a8c-b9cb-2cceb4ede1da", "frameworkName": null, "frameworkSlug": null }, { "bbox": { "h": 0.02, "w": 0.3, "x": 0.01, "y": 0.975 }, "kind": "source-note", "text": "Source: Public company transcripts. Quotes are bolded and underlined for emphasis.", "attrs": null, "subkind": null, "toolName": null, "toolSlug": null, "confidence": null, "componentId": "5388f81a-da52-4f39-b75f-1618958f012b", "frameworkName": null, "frameworkSlug": null }, { "bbox": { "h": 0.12, "w": 0.92, "x": 0.04, "y": 0.03 }, "kind": "title", "text": "In Fact, In 2019, Management Committed to Delivering Innovation – Specifically On 15 Potential Blockbusters", "attrs": null, "subkind": "headline", "toolName": null, "toolSlug": null, "confidence": null, "componentId": "02571639-dd7f-400a-8811-dd2399972efe", "frameworkName": null, "frameworkSlug": null } ], "metrics": [], "tools": [], "frameworks": [ { "name": "ceo-quote-contradiction", "slug": null, "matchId": "d1a6c383-43f4-49bf-af83-69711b6b4214", "evidence": "Uses a past CEO quote to set a benchmark for future performance evaluation.", "confidence": 0.9 } ], "arcBeats": [ { "to": 30, "from": 11, "beatId": "e3d3e281-b7d2-40bf-bf10-c286405c0d64", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Agitate (Make it worse)", "beatSlug": "problem-agitate-solution-agitate-make-it-worse", "evidence": "The document agitates the problem by highlighting Pfizer's lack of internal innovation, failed products, and poor capital allocation.", "position": 1, "confidence": 0.8, "parentBeatName": "Development", "parentBeatSlug": "development" } ], "loops": [ { "to": 20, "from": 12, "name": "Iceberg", "slug": "10-iceberg", "bestFor": "Consulting, complex problem solving, organizational change", "matchId": "5022ccdf-4dc3-4ffa-8bea-f9ccda118289", "evidence": "The document presents a series of slides exposing contradictions between Pfizer's claims and actual results, revealing the iceberg-like issues beneath the surface.", "position": 0, "objective": "What are the reasons behind Pfizer's lack of internal innovation?", "structure": "The Symptom (Visible) -> The System (Hidden) -> The Root Cause", "confidence": 0.7, "description": "Reveal that the visible problem is merely a symptom of a deeper root cause" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }